NCT00646334

Brief Summary

Optilene® Mesh Elastic and Ultrapro® Mesh will be used for incisional hernia repair. The primary objective of this clinical study is to demonstrate that Optilene® Mesh Elastic is superior to Ultrapro® Mesh in incisional hernia repair in matter of the physical function score from the SF-36 questionnaire 21 days after mesh insertion. Secondary objectives include the patient's daily activity, the rating of patients pain and the wound assessment determined on several occasions during the six months observation time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 28, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

May 28, 2015

Status Verified

May 1, 2015

Enrollment Period

4.3 years

First QC Date

March 18, 2008

Last Update Submit

May 27, 2015

Conditions

Keywords

Large Pore Size Propylene MeshIncisional HerniaRandomized Controlled Double-blind Study

Outcome Measures

Primary Outcomes (1)

  • Physical function score of the SF-36 questionnaire

    21 days after insertion

Secondary Outcomes (4)

  • physical function score from the SF-36 questionnaire

    6 months postoperatively

  • patient's daily activity

    6 months postoperatively

  • patient's pain

    6 months postoperatively

  • wound assessment

    6 months postoperatively

Study Arms (2)

A

EXPERIMENTAL

Optilene® Mesh Elastic

Device: Mesh Implantation

B

ACTIVE COMPARATOR

Ultrapro® Mesh

Device: Mesh Implantation

Interventions

An elective incisional Hernia repair is performed by using Optilene® Mesh Elastic, a lightweight and large pore mesh, knitted from monofilament polypropylene. Due to the multidirectional elasticity the mesh is able to adapt to all movements taking place in the abdominal wall.

Also known as: Optilene® Mesh Elastic
A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female or male patients \>=18 years
  • Female patients are incapable of pragnancy or must be using adequate contraception and are not in lactation
  • Patients wiht vertical aponeurotic incisions only
  • Incisional hernia with hernia size \>= 3 cm
  • Patient is capable to understand and to follow the instructions
  • written informed consent
  • no mesh implantation at the same site during a previous operation
  • immune competence of patient

You may not qualify if:

  • Simultanous participation in an investigational drug or medical device study
  • Patients \< 18 years old
  • Incisional Hernia withe a hernia size \< 3 cm
  • Repair of an acute incarcerated hernia
  • Previous mesh repair at the same site
  • Patient with other than vertical aponeurotic incisions
  • Enterotomy to be performed during hernia repair at Surgery
  • Patient is on anti-coagulations-therapy
  • Patient is known or assessed to be non-compliant
  • Additional surgical treatment at the same time (e.g. cholecystectomy)
  • Immune incompetence of patient (e.g. chemotherapy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Universitaetsklinikum Heidelberg

Heidelberg, Baden-Wurttemberg, 69120, Germany

Location

Krankenhaus Salem

Heidelberg, Baden-Wurttemberg, 69121, Germany

Location

Universitaetsklinikum Mannheim

Mannheim, Baden-Wurttemberg, 68167, Germany

Location

Klinikum Aschaffenburg

Aschaffenburg, Bavaria, 63739, Germany

Location

Andreas Kuthe

Hanover, Lower Saxony, 30161, Germany

Location

Albert-Schweitzer Krankenhaus

Northeim, Lower Saxony, 37154, Germany

Location

Related Publications (13)

  • Cassar K, Munro A. Surgical treatment of incisional hernia. Br J Surg. 2002 May;89(5):534-45. doi: 10.1046/j.1365-2168.2002.02083.x.

    PMID: 11972542BACKGROUND
  • Schumpelick V, Arlt G, Klinge U. [Versorgung von Nabelhernien und Narbenhernien]. Dt. Aerzteblatt 94, Heft 51-52. Dez. 1997 (35)

    BACKGROUND
  • Klinge U, Conze J, Limberg W, Brucker C, Ottinger AP, Schumpelick V. [Pathophysiology of the abdominal wall]. Chirurg. 1996 Mar;67(3):229-33. German.

    PMID: 8681695BACKGROUND
  • Klinge U, Conze J, Klosterhalfen B, Limberg W, Obolenski B, Ottinger AP, Schumpelick V. [Changes in abdominal wall mechanics after mesh implantation. Experimental changes in mesh stability]. Langenbecks Arch Chir. 1996;381(6):323-32. doi: 10.1007/BF00191312. German.

    PMID: 9082105BACKGROUND
  • Schumpelick V, Lloyd M. Meshes: benefits and risks, 9 Polypropylene: The standard of Mesh Materials. Nyhus Editors, Springer Verlag, 2004: 101-103

    BACKGROUND
  • Beets GL, Go PM, van Mameren H. Foreign body reactions to monofilament and braided polypropylene mesh used as preperitoneal implants in pigs. Eur J Surg. 1996 Oct;162(10):823-5.

    PMID: 8934114BACKGROUND
  • Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze J, Schumpelick V. Impact of polymer pore size on the interface scar formation in a rat model. J Surg Res. 2002 Apr;103(2):208-14. doi: 10.1006/jsre.2002.6358.

    PMID: 11922736BACKGROUND
  • Benhidjeb T, Baerlehner E, Anders S. Laparoskopische Narbenhernien Reparation: Muss das Netz fuer die Intraperitoneale Onlay-Mesh-Technik besondere Eigenschaften haben?; Chir. Gastroenterol. 2003; 19(Suppl.2): 16-22

    BACKGROUND
  • Rosen HR, Gyasi A; Retromuskulaere Kunststoffnetzimplantation von Narbenhernien; Chir. Gastroenterol.; 2003; 19 (Suppl. 2); 39-45

    BACKGROUND
  • Rosch R, Junge K, Stumpf M, Klinge U, Schumpelick V, Klosterhalfen B; Welche Anforderungen sollte ein ideales Netz erfuellen?; Chir. Gastroenterol.; 2003; 19 (Suppl. 2); 7-11

    BACKGROUND
  • Schumpelick V, van Ackeren H, Klinge U; Hernien; Thieme Verlag, 2000; 266-267

    BACKGROUND
  • Seiler C, Baumann P, Kienle P, Kuthe A, Kuhlgatz J, Engemann R, V Frankenberg M, Knaebel HP. A randomised, multi-centre, prospective, double blind pilot-study to evaluate safety and efficacy of the non-absorbable Optilene Mesh Elastic versus the partly absorbable Ultrapro Mesh for incisional hernia repair. BMC Surg. 2010 Jul 12;10:21. doi: 10.1186/1471-2482-10-21.

    PMID: 20624273BACKGROUND
  • Rickert A, Kienle P, Kuthe A, Baumann P, Engemann R, Kuhlgatz J, von Frankenberg M, Knaebel HP, Buchler MW. A randomised, multi-centre, prospective, observer and patient blind study to evaluate a non-absorbable polypropylene mesh vs. a partly absorbable mesh in incisional hernia repair. Langenbecks Arch Surg. 2012 Dec;397(8):1225-34. doi: 10.1007/s00423-012-1009-6. Epub 2012 Oct 3.

MeSH Terms

Conditions

Incisional Hernia

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Andreas Kuthe, Dr.

    DRK Krankenhaus Clementinenhaus, Hannover

    PRINCIPAL INVESTIGATOR
  • Rainer Engemann, Prof. Dr.

    Klinikum Aschaffenburg, Chirurgische Klinik

    PRINCIPAL INVESTIGATOR
  • Jens Kuhlgatz, Dr.

    Albert-Schweitzer-Krankenhaus, Klinik fuer Allgemein- und Viszeralchirurgie, Zentrum fuer Minimalinvasive Chirurgie, Northeim

    PRINCIPAL INVESTIGATOR
  • Peter Kienle, Prof. Dr.

    Universitaetsklinikum Mannheim, Chirurgische Klinik

    PRINCIPAL INVESTIGATOR
  • Markus Buechler, Prof.Dr.Dr.

    Universitaetsklinikum Heidelberg, Abt. fuer Allgemein-, Viszeral-, Unfallchirurgie und Poliklinik

    PRINCIPAL INVESTIGATOR
  • Moritz von Frankenberg, Dr.

    Krankenhaus Salem, Chirurgische Abteilung, Heidelberg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2008

First Posted

March 28, 2008

Study Start

June 1, 2006

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

May 28, 2015

Record last verified: 2015-05

Locations